Brain Delivery of Multifunctional Dendrimer Protein Bioconjugates
Source abstract
Abstract
Abstract Neurological disorders are undoubtedly among the most alarming diseases humans might face. In treatment of neurological disorders, the blood‐brain barrier (BBB) is a challenging obstacle preventing drug penetration into the brain. Advances in dendrimer chemistry for central nervous system (CNS) treatments are presented here. A poly(amido)amine (PAMAM) dendrimer bioconjugate with a streptavidin adapter for the attachment of dendrons or any biotinylated drug is constructed. In vitro studies on porcine or murine models and in vivo mouse studies are performed and reveal the permeation of dendronized streptavidin (DSA) into the CNS. The bioconjugate is taken up mainly by the caveolae pathway and transported across the BBB via transcytosis escaping from lysosomes. After transcytosis DSA are delivered to astrocytes and neurons. Furthermore, DSA offer high biocompatibility in vitro and in vivo. In summary, a new strategy for implementing therapeutic PAMAM function as well as drug delivery in neuropathology is presented here.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Dendrimers and Hyperbranched Polymers · RNA Interference and Gene Delivery · Advanced Polymer Synthesis and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Physiology University Medical Center of Johannes Gutenberg University Mainz Duesbergweg 6 D‐55128 Mainz Germany
Max Planck Institute for Polymer Research Ackermannweg 10 55128 Mainz Germany
Funding
Institute of Molecular and Cell Biology · Deutsche Forschungsgemeinschaft · Johannes Gutenberg-Universität Mainz · European Research Council
References (70)
Show source-provided references
1. Thakur K. T. · 2016 · 87
2. 10.1016/j.drudis.2015.02.00310.1016/j.drudis.2015.02.003 ↗
3. 10.1124/pr.57.2.410.1124/pr.57.2.4 ↗
4. 10.1016/j.drudis.2006.10.01310.1016/j.drudis.2006.10.013 ↗
5. 10.1602/neurorx.2.1.310.1602/neurorx.2.1.3 ↗
6. 10.1208/s12248-008-9018-710.1208/s12248-008-9018-7 ↗
7. 10.3171/2011.10.FOCUS1125210.3171/2011.10.FOCUS11252 ↗
8. 10.1592/phco.29.7.83210.1592/phco.29.7.832 ↗
9. 10.1021/acsnano.6b0385810.1021/acsnano.6b03858 ↗
10. 10.2174/15680091279927742110.2174/156800912799277421 ↗
11. Begley D. J. · Prog. Drug Res. · 2003 · 61 · 39
12. 10.1038/nrd.2015.2110.1038/nrd.2015.21 ↗
13. 10.1016/j.addr.2013.08.00810.1016/j.addr.2013.08.008 ↗
14. 10.15171/bi.2016.3010.15171/bi.2016.30 ↗
15. V.Leiro S.Duque Santos C. D. F.Lopes A.Paula Pêgo.
16. 10.1021/bm301165u10.1021/bm301165u ↗
17. 10.1016/j.biomaterials.2009.11.08510.1016/j.biomaterials.2009.11.085 ↗
18. 10.1021/bm500328v10.1021/bm500328v ↗
19. 10.1021/bm400948z10.1021/bm400948z ↗
20. 10.1007/s11095-013-1005-810.1007/s11095-013-1005-8 ↗
21. 10.1007/s11095-009-9839-910.1007/s11095-009-9839-9 ↗
22. Gamage N. H. · J. Nanomed. Nanotechnol. · 2016 · 7 · 393
23. 10.1016/j.jconrel.2014.12.04210.1016/j.jconrel.2014.12.042 ↗
24. 10.2217/nnm.10.8910.2217/nnm.10.89 ↗
25. 10.1016/j.biomaterials.2016.05.04410.1016/j.biomaterials.2016.05.044 ↗
26. 10.1016/j.jconrel.2017.01.03210.1016/j.jconrel.2017.01.032 ↗
27. 10.1186/s12974-017-1004-510.1186/s12974-017-1004-5 ↗
28. 10.1016/j.progpolymsci.2016.09.00610.1016/j.progpolymsci.2016.09.006 ↗
29. 10.2174/138161282066615082709434110.2174/1381612820666150827094341 ↗
30. 10.1021/bc500622410.1021/bc5006224 ↗
31. 10.1073/pnas.96.25.1452910.1073/pnas.96.25.14529 ↗
32. 10.1016/j.biomaterials.2015.02.05310.1016/j.biomaterials.2015.02.053 ↗
33. 10.1073/pnas.132235611110.1073/pnas.1322356111 ↗
34. 10.1161/01.ATV.0000070546.16946.3A10.1161/01.ATV.0000070546.16946.3A ↗
35. 10.1021/mp900246410.1021/mp9002464 ↗
36. 10.1016/j.brainres.2013.04.00610.1016/j.brainres.2013.04.006 ↗
37. 10.1124/dmd.105.00643710.1124/dmd.105.006437 ↗
38. 10.4103/1673-5374.15834210.4103/1673-5374.158342 ↗
39. 10.1021/am405219u10.1021/am405219u ↗
40. 10.1073/pnas.151704811210.1073/pnas.1517048112 ↗
41. 10.1016/S0022-3565(24)35204-810.1016/S0022-3565(24)35204-8 ↗
42. 10.1038/s41598-017-11220-110.1038/s41598-017-11220-1 ↗
43. 10.1016/j.biomaterials.2012.06.06310.1016/j.biomaterials.2012.06.063 ↗
44. 10.1186/2045-8118-10-510.1186/2045-8118-10-5 ↗
45. 10.1016/S0928-0987(00)00152-410.1016/S0928-0987(00)00152-4 ↗
46. 10.1016/j.yexcr.2007.06.00810.1016/j.yexcr.2007.06.008 ↗
47. 10.1128/MCB.21.5.1573-1580.200110.1128/MCB.21.5.1573-1580.2001 ↗
48. 10.7150/thno.1658710.7150/thno.16587 ↗
49. Cherra S. J. · Future Neurol. · 2008 · 3 · 30910.2217/14796708.3.3.309 ↗
50. 10.1038/sj.cdd.440175110.1038/sj.cdd.4401751 ↗
51. 10.4161/15548627.2014.97333810.4161/15548627.2014.973338 ↗
52. 10.1007/978-1-59745-157-4_410.1007/978-1-59745-157-4_4 ↗
53. 10.1080/15548627.2015.106695710.1080/15548627.2015.1066957 ↗
54. 10.1016/j.brainres.2014.01.01710.1016/j.brainres.2014.01.017 ↗
55. Liang W. · 2012 · 17
56. 10.1016/j.jpba.2006.06.02110.1016/j.jpba.2006.06.021 ↗
57. 10.1039/b601381c10.1039/b601381c ↗
58. 10.1177/01617346080300030410.1177/016173460803000304 ↗
59. Abbott N. J. · 2014 · 310.1007/978-1-4614-9105-7_1 ↗
60. 10.3390/ijms1803062810.3390/ijms18030628 ↗
61. 10.1016/j.biomaterials.2009.08.04910.1016/j.biomaterials.2009.08.049 ↗
62. 10.1073/pnas.96.12.705310.1073/pnas.96.12.7053 ↗
63. 10.1038/nbt.333010.1038/nbt.3330 ↗
64. Kozler P. · Physiol. Res. · 2003 · 52 · 60710.33549/physiolres.930289 ↗
65. 10.1002/adhm.20120041910.1002/adhm.201200419 ↗
66. 10.1016/j.neulet.2014.01.01410.1016/j.neulet.2014.01.014 ↗
67. 10.1073/pnas.95.23.1336310.1073/pnas.95.23.13363 ↗
68. 10.1021/bm301531c10.1021/bm301531c ↗
69. 10.1083/jcb.115.6.172510.1083/jcb.115.6.1725 ↗
70. 10.1111/j.1365-2818.2006.01706.x10.1111/j.1365-2818.2006.01706.x ↗